A detailed history of Fifth Third Bancorp transactions in Boston Scientific Corp stock. As of the latest transaction made, Fifth Third Bancorp holds 218,946 shares of BSX stock, worth $21.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
218,946
Previous 216,941 0.92%
Holding current value
$21.5 Million
Previous $16.7 Million 9.82%
% of portfolio
0.07%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$72.96 - $84.0 $146,284 - $168,420
2,005 Added 0.92%
218,946 $18.3 Million
Q2 2024

Jul 22, 2024

BUY
$67.33 - $77.71 $529,146 - $610,722
7,859 Added 3.76%
216,941 $16.7 Million
Q1 2024

Apr 23, 2024

BUY
$57.6 - $68.62 $11,520 - $13,724
200 Added 0.1%
209,082 $14.3 Million
Q4 2023

Jan 19, 2024

SELL
$48.64 - $57.81 $733,783 - $872,121
-15,086 Reduced 6.74%
208,882 $12.1 Million
Q3 2023

Oct 31, 2023

SELL
$50.19 - $54.68 $1.29 Million - $1.4 Million
-25,611 Reduced 10.26%
223,968 $11.8 Million
Q2 2023

Jul 25, 2023

SELL
$49.72 - $54.64 $721,486 - $792,881
-14,511 Reduced 5.49%
249,579 $13.5 Million
Q1 2023

Apr 24, 2023

BUY
$45.09 - $50.03 $2.32 Million - $2.57 Million
51,458 Added 24.2%
264,090 $13.2 Million
Q4 2022

Jan 25, 2023

SELL
$39.56 - $47.22 $712,950 - $850,998
-18,022 Reduced 7.81%
212,632 $0
Q3 2022

Oct 25, 2022

SELL
$36.71 - $109.66 $460,894 - $1.38 Million
-12,555 Reduced 5.16%
230,654 $8.93 Million
Q2 2022

Aug 04, 2022

SELL
$35.24 - $47.1 $227,121 - $303,559
-6,445 Reduced 2.58%
243,209 $9.06 Million
Q1 2022

Apr 19, 2022

SELL
$40.9 - $45.1 $1.58 Million - $1.74 Million
-38,624 Reduced 13.4%
249,654 $11.1 Million
Q4 2021

Feb 01, 2022

SELL
$38.07 - $44.87 $1.3 Million - $1.53 Million
-34,148 Reduced 10.59%
288,278 $12.2 Million
Q3 2021

Oct 15, 2021

SELL
$41.23 - $45.88 $5.84 Million - $6.5 Million
-141,663 Reduced 30.52%
322,426 $14 Million
Q2 2021

Aug 06, 2021

SELL
$38.58 - $44.24 $2.05 Million - $2.35 Million
-53,129 Reduced 10.27%
464,089 $19.8 Million
Q1 2021

May 07, 2021

SELL
$35.27 - $39.67 $4.5 Million - $5.06 Million
-127,547 Reduced 19.78%
517,218 $20 Million
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $6.08 Million - $7.69 Million
-183,330 Reduced 22.14%
644,765 $23.2 Million
Q3 2020

Nov 09, 2020

BUY
$34.44 - $42.23 $8.07 Million - $9.9 Million
234,317 Added 39.46%
828,095 $31.6 Million
Q2 2020

Aug 05, 2020

BUY
$30.19 - $39.11 $2.6 Million - $3.36 Million
85,964 Added 16.93%
593,778 $20.8 Million
Q1 2020

May 05, 2020

BUY
$25.83 - $45.71 $4.62 Million - $8.18 Million
178,897 Added 54.39%
507,814 $16.6 Million
Q4 2019

Feb 14, 2020

BUY
$37.87 - $45.37 $719,227 - $861,667
18,992 Added 6.13%
328,917 $14.9 Million
Q3 2019

Nov 14, 2019

BUY
$40.31 - $43.45 $504,237 - $543,516
12,509 Added 4.21%
309,925 $12.6 Million
Q2 2019

Aug 07, 2019

SELL
$34.91 - $42.98 $10.3 Million - $12.7 Million
-295,327 Reduced 49.82%
297,416 $12.8 Million
Q1 2019

May 14, 2019

SELL
$32.91 - $40.75 $5.02 Million - $6.22 Million
-152,564 Reduced 20.47%
592,743 $22.7 Million
Q4 2018

Feb 14, 2019

SELL
$31.73 - $39.04 $3.52 Million - $4.33 Million
-110,921 Reduced 12.95%
745,307 $26.3 Million
Q3 2018

Nov 14, 2018

BUY
$32.83 - $38.63 $488,050 - $574,273
14,866 Added 1.77%
856,228 $33 Million
Q2 2018

Aug 14, 2018

BUY
$26.84 - $34.32 $3.16 Million - $4.04 Million
117,682 Added 16.26%
841,362 $27.5 Million
Q1 2018

May 15, 2018

BUY
$25.2 - $28.54 $11.3 Million - $12.8 Million
448,957 Added 163.42%
723,680 $19.8 Million
Q4 2017

Feb 14, 2018

BUY
$24.79 - $29.8 $6.6 Million - $7.94 Million
266,310 Added 3165.46%
274,723 $6.81 Million
Q3 2017

Nov 14, 2017

BUY
$26.26 - $29.17 $44,642 - $49,589
1,700 Added 25.32%
8,413 $245,000
Q2 2017

Aug 11, 2017

BUY
N/A
6,713
6,713 $186,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $141B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.